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ABSTRACT 
Migraine is a commonly-occurring primary headache disorder that is often comorbid with 
many conditions, including depression, anxiety, and sleep disorders. Previous research has 
shown that sleep problems are common among migraineurs, with insomnia being the most 
prevalent. Insomnia in migraineurs has many possible causes, including inadequate sleep 
hygiene, or participating in behaviors that are not conducive to sleep. Modifying sleep hygiene 
behavior has been shown to be effective in reducing migraine intensity and frequency, but 
research characterizing the specific sleep hygiene behaviors of migraineurs is limited. The 
present study sought to identify problematic sleep behaviors and their association with episodic 
migraine so as to inform the development and refinement of behavioral sleep interventions to 
reduce migraine frequency, intensity, and disability. The present study also explored anxiety and 
depression and their relation to migraine, sleep hygiene, and insomnia among college students, a 
population of interest because of their high rates of migraine, sleep disturbance, and 
psychological comorbidities. 
 The sample consisted of 323 college students with a mean age of 19.28 years (SD = 
3.38), with 84 (26%) meeting ICHD-II criteria for episodic migraine and 8 (2.5%) for chronic 
migraine. Episodic migraineurs reported significantly poorer overall sleep hygiene compared to 
controls (Sleep Hygiene Index M = 38.24 [SD = 6.71] v. 36.54 [SD = 6.06], p < .05). After 
controlling for symptoms of insomnia, anxiety, and depression, which were significantly higher 
among migraineurs, however, these differences were rendered nonsignificant. Among episodic 
migraineurs, linear regression analyses showed that poorer sleep hygiene significantly predicted 
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headache-related disability but not migraine severity or frequency. An argument is presented that 
sleep hygiene is less important among episodic than chronic migraineurs, and directions for 
future research are discussed. 
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Examining the Sleep Hygiene Behaviors of Migraineurs in a University Setting 
 
Introduction 
Migraine Diagnosis 
Migraine is a commonly-occurring primary headache disorder that can be extremely 
disabling and can have a major impact on many areas of an individual’s life. Migraine has a 
lifetime prevalence of 12% among the general population and 18-20% among women (Fukui et 
al., 2008; Jette, Patten, Williams, Becker, & Wiebe, 2008). Many studies have shown that 
migraine is up to four times more common among women than among men (Jelinski et al., 2006; 
Lyngberg, Rasmussen, Jorgensen, & Jensen, 2005; Stewart, Lipton, Celentano, & Reed, 1992) 
and is most prominent between the ages of 25 and 44 years (Lipton et al., 2002; Pryse-Phillips et 
al., 1992). The World Health Organization has ranked migraine as number 19 among all diseases 
worldwide that cause disability (Leonardi, Musicco, & Nappi, 1998).  
 Diagnostic criteria for migraine and other headache disorders are outlined in the 
International Classification of Headache Disorders, 2nd Edition (ICHD-II; Headache 
Classification Subcommittee of the International Headache Society [IHS], 2004). Migraine is 
defined as “a recurrent headache disorder manifesting in attacks lasting 4-72 hours” either 
untreated or unsuccessfully treated (IHS, 2004, p. 24). Typical characteristics of migraine attacks 
are “unilateral location, pulsating/throbbing quality, moderate or severe intensity, aggravation by 
routine physical activity, and association with nausea and/or vomiting and/or photophobia and 
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phonophobia” (IHS, 2004, p. 24-25). Migraine can be divided into two major sub-types: 
migraine without aura (1.1) and migraine with aura (1.2). Though less common than migraine 
without aura, migraine with aura is distinctively characterized by neurological symptoms (aura) 
that are usually visual innature and precede or sometimes accompany the other features of 
migraine. Typical aura (1.2.1) consists of at least one of the following: “fully reversible visual 
symptoms including positive features (e.g. flickering lights, spots or lines) and/or negative 
features (i.e. loss of vision), fully reversible sensory symptoms including positive features (i.e. 
pins and needles) and/or negative features (i.e. numbness), or fully reversible dysphasic speech 
disturbance” (IHS, 2004, p. 26-27).   
Comorbidity of Migraine 
The prevalence of co-occurring psychological disorders (i.e., psychological comorbidity) 
in migraineurs has been explored frequently. Migraine is comorbid with disorders such as major 
depressive disorder, generalized anxiety disorder, panic disorder, bipolar disorder, and social 
phobia (Breslau & Davis, 1992, 1993; Breslau, Davis, Schultz, & Peterson, 1994; Breslau, 
Lipton, Stewart, Schultz, & Welch, 2003; Breslau, Shultz, Stewart, Lipton, & Welch, 2001; 
Ettinger, Reed, Goldberg, & Hirschfeld, 2005; Lipton, Hamelsky, Kolodner, Steiner, & Stewart, 
2000; McIntyre et al., 2006; Stewart, Breslau, & Keck, 1994). Conflicting findings exist 
pertaining to the comorbidity of substance use disorders with migraine (Jette et al., 2008; 
Saunders, Merikangas, Low, Von Korff, & Kessler, 2008; Swartz, Pratt, Armenian, Lee, & 
Eaton, 2000). The most common classes of psychological disorders that are comorbid with 
migraine are depressive and anxiety disorders (Lanteri-Minet, Radat, Chautard, & Lucas, 2005; 
Oedegaard et al., 2006). Several large-scale population-based studies have shown that 
migraineurs are two to four times more likely to suffer from depression and anxiety disorders 
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than are individuals in the general population without migraine (Boardman, Thomas, Millson, & 
Croft, 2005; Breslau et al., 1994, 2003; Jette et al., 2008; Merikangas, Angst, & Isler, 1990; 
Ohayon, 2004), with panic disorder and phobias being the most common comorbid anxiety 
disorders (Breslau & Davis, 1992; Breslau et al., 2001; Radat & Swendsen, 2005; Stewart et al., 
1994).  
A bidirectional relationship has been implicated for migraine and depression, suggesting 
that each disorder increases risk for onset of the other and arguing against the traditional notion 
that depression is merely a response to living with disabling migraines (Breslau et al., 1994, 
2003). A bidirectional relationship has also been implicated between migraine and panic disorder 
(Breslau et al., 2001), although further research is needed to clarify the temporal relationship 
between anxiety disorders and migraine. These findings suggest that psychological comorbidities 
may share etiological pathways with migraine. As one example, reduced serotonergic 
transmission is common in both migraine and anxiety/depression (Breslau et al., 1994; 
Panconesi, 2008), and both conditions respond favorably to medications that increase 
serotonergic activity.  
Psychological comorbidities in migraineurs have become an increasing concern since the 
World Health Organization has ranked both migraine and major depressive disorder as leading 
causes of disability worldwide (Jette et al., 2008; Simon, 2003; Ustun & Kessler, 2002), with 
anxiety disorders also ranked as highly disabling among psychological disorders (Kessler, Chiu, 
Demler, & Walters, 2005). Studies have already shown that migraine (with and without 
psychological comorbidity) causes a significant reduction in quality of life, loss of productivity, 
and increased health care costs, among other practical liabilities (Hu, Markson, Lipton, Stewart, 
& Berger, 1999; Lipton et al., 2000; Von Korff, Stewart, Simon, & Lipton, 1998; Baskin & 
	  4	  
Smitherman, 2009). Furthermore, it is important to identify psychological comorbidities in 
migraineurs because these comorbidities may complicate the diagnosis and treatment of 
migraine, affect treatment adherence, or alter the course of migraine (Baskin, Lipchik, & 
Smitherman, 2006; Baskin & Smitherman, 2009).  
Role of Sleep Dysfunction in Migraine 
In addition to research on affective comorbidities, headache researchers have begun to 
look at other comorbidities (Peres, Young, Kaup, Zukerman, & Silberstein, 2001; Peres, 
Zukerman, Young, & Silberstein, 2002). Some of the most common other comorbidities that 
accompany migraine are sleep disorders. Sleep disorders that are comorbid with migraine and 
other headache include circadian rhythm disorders (Ohayon, 2005), chronic snoring (Jennum, 
Hein, Suadicani, & Gyntelberg, 1994), sleep apnea (Ulfberg, Carter, Talback, & Eding, 1996) 
and other sleep-related breathing disorders (Olson, King, Hensley, & Saunders, 1995), 
parasomnias (Goder et al., 2003), and hypersomnia (Goder et al., 2003). The most common sleep 
disorder in migraineurs, however, is insomnia (Maizels & Burchette, 2004; Ohayon, 2004; Paiva, 
Martins, Batista, Esperanca, & Martins, 1994; Rains & Poceta, 2006; Rothrock, Patel, Lyden, & 
Jackson, 1996).  
Early research on headache and sleep was unclear as to whether sleep disturbance 
consistently accompanies migraine in the absence of other psychological comorbidities or 
whether sleep disturbance is a complication of co-occurring psychological disorders (Wright, 
1871). However, current research has shown that a disproportionate prevalence of sleep 
disturbances in migraine persists even after controlling for psychological comorbidities such as 
anxiety and depression (Vgontzas, Cui, & Merikangas, 2008) and is thus not merely a 
consequence of affective comorbidities. Not only has migraine been implicated to precede sleep 
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disturbance (Inamorato, Minatti-Hannuch, & Zukerman, 1993; Marcus, 2006), but insomnia and 
the aforementioned sleep disturbances also often function as “triggers” for migraine (Fukui et al., 
2008; Kelman, 2007; Spierings, Ranke, & Honkoop, 2001). 
A migraine trigger is an environmental or physiological event that produces (or 
predisposes an individual to) a migraine attack. Many studies have examined the different types 
of migraine triggers, though most of them rely on retrospective recall rather than prospective 
data. Kelman (2007) found that 75.9% of migraineurs reported experiencing triggers, with 35.5% 
reporting that they occurred at least frequently and 94.6% reporting that they occurred at least 
occasionally. Sixty-one percent of patients reported having between four and nine triggers (M = 
6.7; Mdn = 7.7). The most common triggers reported were stress, hormonal changes (in women), 
not eating, weather changes, and sleep disturbances, all of which were present in roughly 50% of 
the migraine sample. Another study by Fukui et al. (2008) found that dietary factors, sleep 
disturbance, environmental factors, and stress were among the most common migraine triggers. 
Marcus (2003) found that 26% of approximately 300 headache patients reported changes in sleep 
as a trigger for migraine. Similarly, Jerusalimschy and Moreira-Filho (2002) found that 49% of 
headache patients reported sleep disturbance as a trigger for their headache. More specifically, 
Spierings et al. (2001) found that 74% reported sleeplessness as a headache trigger. Taken 
together, and despite large variability in estimates, these studies provide strong support for the 
notion that sleep disturbances are common among migraineurs and function frequently as 
migraine triggers (for ¼ to ¾ of migraineurs).  
The rate at which sleep disturbances co-occur with migraine (even when controlling for 
other comorbidities) is suggestive of a potential shared etiology between these conditions. It has 
been suggested that migraine can occur because of circadian changes in levels of serotonin, 
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melatonin, and magnesium (Dodick, Eross, & Parish, 2003; Marcus, 2006). At night, circulating 
tryptophan is converted to serotonin in the pineal gland, which is then converted to melatonin. 
Serotonin and melatonin released from the pineal gland influence activity of the 
trigeminovascular system (Marcus, 2006; Toglia, 2001). Altered neuronal activity in the 
trigeminovascular system (specifically the trigeminal nerve, spinal trigeminal nucleus, and 
thalamus) elicits migraine through nociceptive afferents to the brain and meningeal blood 
vessels, which causes the perception of pain (Messlinger, 2009). Although evidence is growing 
that sleep and migraine share common pathophysiology, further research is needed to clarify the 
mechanisms that underpin this relationship.  
Insomnia in Migraine 
Insomnia is typically defined in research studies as a sleep disturbance characterized by 
getting ≤ 6 hours of continuous sleep, difficulty falling asleep or staying asleep, early morning 
awakening or non-restorative sleep, and daytime consequences such as sleepiness. The 
International Classification of Sleep Disorders- 2nd edition (ICSD-2; AASM, 2005) classifies 
insomnia by its severity: mild, moderate, or severe. With mild insomnia there is little to no 
evidence of impairment in functioning, with moderate insomnia there is mild to moderate 
evidence of impairment in social or occupational functioning, and with severe insomnia there is 
obvious and severe impairment in functioning. All severities are associated with feelings of 
restlessness, irritability, mild anxiety, daytime fatigue, and tiredness (AASM, 2005).  
Insomnia or insomnia-like symptoms are often present in migraineurs. Fukui et al. (2008) 
found that among reported sleep disturbances, lack of sleep occurred in 61.5% of migraineurs. 
More specifically, in one of the largest samples of migraineurs studied to date (Kelman & Rains, 
2005), 38% of 1,283 migraineurs suffered from insomnia-like symptoms (sleeping no more than 
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6 hours per night), compared with 10% of the general population (AASM, 2005). Thirty-one 
percent of migraineurs reported problems falling asleep and 39% reported problems staying 
asleep. In this study, greater frequency of migraine was related to shorter sleep episodes, in that 
patients with chronic migraine reported shorter sleep episodes than those with episodic migraine. 
Gori et al. (2005) also found that poor sleep was reported by 64% of migraineurs compared to 
33% of controls. The most commonly reported sleep disturbance was inability to fall asleep. 
Although the range of these percentages is large, it is clear that migraineurs are significantly 
more likely to suffer from insomnia-like symptoms than are those without migraine. Indeed, the 
finding of insomnia as the most commonly reported sleep disturbance is consistent throughout 
the migraine literature (Blau, 1990; Calhoun & Ford, 2007; Calhoun, Ford, Finkel, Kahn, & 
Mann, 2006; Inamorato et al., 1993; Rains & Poceta, 2006). Specifically, odds ratios of having 
insomnia for a migraineur versus nonmigraineur have been reported as 2.1 (Ohayon, 2004), 2.9 
(Rasmussen, 1993), and 2.5 (Vgontzas et al., 2008).   
Insomnia can be precipitated by many factors. These may include substance or stimulant 
use, a comorbid anxiety or mood disorder, pain or another medical condition, being in an 
environment that is not conducive to sleep, or by engaging in behaviors that are not conducive to 
sleep (Calhoun et al., 2006). Most of these environmental factors and behaviors that are not 
conducive to sleep can be classified as inadequate sleep hygiene. 
Inadequate Sleep Hygiene 
Inadequate sleep hygiene (ISH) is defined in the ICSD-R (AASM, 2001) as a “sleep 
disorder due to the performance of daily living activities that are inconsistent with the 
maintenance of good quality sleep and full daytime alertness” (AASM, 2001, p. 73). The newest 
version of the ICSD, the ICSD-2 (AASM, 2005), describes ISH as one of eleven disorders that 
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contributes to insomnia. At least one of the following behaviors must be present in order qualify 
for a diagnosis of ISH (however, many are often present):  
1) Daytime napping at least two times each week, 2) variable wake-up times or bedtimes, 
3) frequent periods (two to three times per week) of extended amounts of time spent in 
bed, 4) routine use of products containing alcohol, tobacco, or caffeine in the period 
preceding bedtime, 5) scheduling exercise too close to bedtime, 6) engaging in exciting 
or emotionally upsetting activities too close to bedtime, 7) frequent use of the bed for 
non-sleep-related activities (e.g., television watching, reading, studying, snacking, etc.), 
8) sleeping on an uncomfortable bed (poor mattress, inadequate blankets, etc.), 9) 
allowing the bedroom to be too bright, too stuffy, too cluttered, too hot, too cold, or in 
some way not conducive to sleep, 10) performing activities demanding high levels of 
concentration shortly before bed, or 11) allowing mental activities, such as thinking, 
planning, reminiscing, etc., to occur in bed (AASM, 2001, p. 76).  
Complaints of insomnia or excessive sleepiness, or abnormal polysomnography findings, 
are also required to receive a formal diagnosis of ISH. ISH is present in approximately 2% of the 
general population and in 5-10% of sleep clinic samples (AASM, 2005).  
Many of the aforementioned behaviors disturb sleep (Riedel, 2000; Stepanski & Wyatt, 
2003) and there is a significant association between poor global sleep hygiene and poor sleep 
quality (Brown, Buboltz, & Soper, 2002; Gallasch & Gradisar, 2007; Lacks & Rotert, 1986; 
Mastin, Bryson, & Corwyn, 2006). For example, Brown et al. (2002) found that variable sleep 
schedules, going to bed thirsty, environmental noise, and worrying while falling asleep 
contributed most to reported poor sleep quality. Other studies have reported similar findings 
(Jefferson et al., 2005; Yang, Lin, Hsu, & Cheng, 2010). Inadequate sleep hygiene is sometimes 
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hard to identify because it is often confused with environmental sleep disorder (because of 
symptom overlap) (AASM, 2005) or is often ignored as a cause for the primary diagnosis of 
insomnia (Buysse et al., 1994). A DSM-IV (APA, 1994) field trial conducted by the American 
Psychological Association/National Institute of Mental Health showed that only 6.2% of patients 
in sleep clinics with a presenting complaint of insomnia were given a primary diagnosis of ISH 
(Buysse et al., 1994). However, when secondary diagnoses were included, 34.2% of the patients 
held a diagnosis of ISH. 	  
Research is relatively consistent, however, in finding that ISH behaviors (regardless of 
formal diagnosis) are associated with poor sleep. An early survey using the Sleep Hygiene 
Awareness and Practice Scale (Lacks & Rotert, 1986) found that insomnia patients engaged in 
more unhealthy sleep habits than those who slept well (Lacks & Rotert, 1986). A more recent 
study using the same scale reported similar results, with poorer sleep hygiene practices in both 
primary insomnia patients and those with insomnia-like symptoms resulting from a 
psychological disorder (Kohn & Espie, 2005). Another study compared insomnia patients with 
non-insomnia controls and found that insomniacs engaged in more maladaptive sleep hygiene 
practices, including cigarette smoking, alcohol use, napping, and having more variable sleep-
wake schedules (Jefferson et al., 2005). In another study (Yang et al., 2010), arousal-related 
behaviors such as watching TV in bed, worrying before going to sleep, or doing important work 
before bedtime were found to be significantly different between insomniacs and controls. Taken 
together, these studies suggest that poor sleep hygiene is a significant factor in insomnia and 
related sleep complaints, even though ISH often remains undiagnosed in individuals who suffer 
from insomnia (Gellis & Lichstein, 2009).	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Sleep Hygiene Treatment 
Good sleep hygiene may be described as practicing behaviors that facilitate sleep and 
avoiding behaviors that interfere with sleep. Sleep hygiene is usually assessed by the self-report 
of nighttime behaviors and environmental variables thought to be nonconducive to sleep. Test-
retest reliability analysis analyses suggest that these sleep hygiene behaviors are relatively stable 
over time (Mastin et al., 2006). A study by Brown et al. (2002) surveyed university students and 
found that the practice of proper sleep habits was related positively to good sleep quality, 
confirming that sleep hygiene behaviors are valid predictors of other important sleep-related 
variables. Because of their importance in sleep disorders, modifying sleep hygiene behaviors has 
become an integral part of interventions designed to improve sleep. Hauri first introduced sleep 
hygiene as a treatment for insomnia in 1977. Today, sleep hygiene treatment is often subsumed 
as a component of other behavioral sleep interventions such as stimulus control therapy, sleep 
hygiene education, or behavioral sleep modification (Calhoun & Ford, 2007; Edinger et al., 
2009; Morin et al., 2006). Although the treatment strategies have evolved over the years and 
sometimes vary from study to study, the underlying principles are the same. The basic principles 
involve psychoeducation about the role of behavior in sleep, training in basic behavioral 
strategies to facilitate sleep, training in environmental modification, and instructions to self-
monitor and practice these behaviors on a daily basis (Calhoun & Ford, 2007; Edinger et al., 
2009; Morin et al., 2006; Vincent & Lewycky, 2009). Sample sleep hygiene strategies might 
include avoiding caffeine and alcohol in the evening, avoiding daytime naps, avoiding large 
meals prior to bedtime, and arranging a sleep environment that is conducive to sleep (e.g., not 
too hot or cold).  
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A study by Vincent and Lewycky (2009) found that sleep hygiene and stimulus control 
therapy were effective treatments for insomnia. In fact, a review by Morin et al. (2006) included 
stimulus control therapy and cognitive behavioral therapy (CBT; with sleep hygiene as a major 
component) as empirically supported treatments for insomnia. Like CBT, most other insomnia 
treatment programs have incorporated sleep hygiene as one facet of a multicomponent approach 
to treatment that typically includes relaxation training, cognitive therapy, stimulus control, and/or 
sleep restriction therapy (Morin et al., 2006). A study by Scholcket, Bertelson, and Lacks (1988) 
evaluated meditation, stimulus control therapy, and sleep hygiene as treatments for insomnia. 
They found that sleep hygiene was effective in treating insomnia, as were the other treatments, 
but this study had no control group for comparison. Friedman et al. (2000) compared sleep 
hygiene to other behavioral sleep interventions and found that sleep hygiene treatment alone was 
just as effective as combined sleep hygiene/sleep restriction therapy and combined nap 
modification (of sleep restriction therapy)/sleep hygiene. On the other hand, a study by Edinger 
et al. (2009) showed that sleep hygiene was not as effective as CBT at treating insomnia, the 
latter which included sleep hygiene education and stimulus control therapy in combination with 
sleep restriction. These studies in combination suggest that sleep hygiene, often as part of a 
larger treatment module, is effective in treating insomnia. 
Sleep Hygiene in Migraineurs 
Despite the role of insomnia and sleep disorders in migraine (both as triggers and 
comorbidities), the utility of using sleep hygiene interventions to reduce migraine has been 
explored only recently. In one of the only migraine-specific studies to date, Calhoun and Ford 
(2007) hypothesized that behavioral sleep modification (BSM) would be associated with 
improvement in headache frequency and intensity in a group of treatment-seeking females with 
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chronic migraine. They randomly assigned 43 women to receive either one session of BSM 
instructions or one session of ‘sham’ instructions. BSM consisted of providing participants a set 
of five sleep hygiene instructions including: 1) scheduling a consistent bedtime allowing eight 
hours in bed, 2) eliminating TV watching, reading, and music in bed, 3) using visualization 
techniques prior to sleep, 4) eating dinner at least four hours prior to bed and limiting fluids 
within two hours of bedtime, and 5) discontinuing naps. All participants received usual medical 
care in addition to either the behavioral intervention or the sham/placebo intervention.  
Compared to the placebo group, the BSM group experienced significantly greater 
reductions in headache frequency and intensity at six-week follow-up. Thirty-five percent of 
chronic migraineurs reverted to episodic migraine within this time period, compared to none of 
the patients in the placebo group. Once the blind was broken and participants were followed for 
another six weeks, 48% had reverted to episodic migraine. Compliance with the BSM 
intervention was positively correlated with improvement, such that participants adhering to all 
five instructions reported the most improvement. On the other hand, participants who adhered to 
less than three instructions did not see a significant reduction in headache frequency or intensity. 
This study showed that a brief behavioral intervention including sleep hygiene	  is effective in 
reducing the frequency and intensity of migraine among those with chronic migraine. Another 
study by Bruni, Galli, and Guidetti (1999) also found sleep hygiene modification effective at 
reducing migraine frequency and duration among children and adolescents with migraine, but the 
specific treatment instructions were not clearly outlined in the publication of this study. 	  
Whereas other studies (Gellis & Lichstein, 2009; Jefferson et al. 2005) have examined 
specific sleep behaviors characteristic of insomniacs, research on the specific sleep behaviors 
common to migraineurs is sparse. Only one study has examined sleep behaviors common to 
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adult migraineurs. Calhoun et al. (2006) surveyed females with transformed (chronic) migraine 
presenting to a headache center. They found that chronic migraineurs consistently engaged in a 
number of maladaptive sleep behaviors, such as watching TV or reading in bed (78.9%), nocturia 
(70.1%; i.e., due to eating or drinking prior to bedtime), taking naps (63.3%), and spending too 
much (≥ 9.5 hours; 18.5%) or too little (≤ 6.5 hours; 18.5%) time in bed. Further, a significant 
minority reported drinking alcohol during the week (0-1 drinks per week, 79.5%; 2-4 drinks, 
15.6%). However, this study did not contain a migraine-free control group for comparison and 
did not consider sleeping to relieve migraine as napping. This study also did not include men or 
individuals with episodic migraine. Another study by Bruni et al. (1997, 1999) examined specific 
sleep behaviors in children and adolescent migraineurs. They found that the migraine 
participants consistently fell asleep later (after 11 p.m.- 16.0% v. 7.0%, p < .001), woke up later 
(after 8 a.m.- 3.5% v. 0.2%, p < .0001), napped more during the day (7.4% v. 3.3%, p < .005), 
and had a more varied bedtime (10.6% v. 5.8%, p < .05) and waking time (9.2% v. 1.7%, p < 
.0001) than did the nonmigraineurs. This study selected and treated only the most sleep-disturbed 
migraineurs and used only some of the AASM (2001, 2005) criteria to characterize poor sleep 
hygiene. The criteria included: bedtime later than 11 p.m., waking time later than 8 a.m., napping 
during the day, irregular schedule (bedtime and wake time varying by more than one hour on 
school days), caffeine in the late afternoon or evening, and the need to drink fluids or take drugs 
to facilitate sleep. The study required that at least two of these criteria be met in order to be 
characterized as poor sleep hygiene. Thus, while the existing literature has provided some 
preliminary evidence that modifying sleep hygiene behaviors is effective in reducing migraine 
frequency, evidence is lacking regarding which specific sleep hygiene behaviors are common 
and problematic among adult episodic migraineurs in community samples. 
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Goals and Hypotheses of the Present Study 
The aims of the present study were to identify the specific maladaptive sleep behaviors 
that distinguish migraineurs from individuals without migraine, assess relations between sleep 
hygiene and migraine variables, and assess the roles of depression and anxiety in sleep hygiene 
practices. Unlike the Calhoun et al. (2006) study that lacked a control group, the current study 
used individuals without migraine as a control group. The current study also included men and 
individuals with episodic migraine. College students served as participants in the current study in 
order to elucidate the relationship between migraine and specific problematic sleep behaviors in 
a non-treatment-seeking community sample.  
College students were recruited as participants due to their inconsistent sleep patterns and 
maladaptive sleep behaviors, and because there is a paucity of research in this area despite the 
high prevalence of both sleep problems and migraine among college students. Approximately 
25% of college students suffer from migraine (Bigal, Bigal, Betti, Bordini, & Speciali, 2001), 
and the prevalence of migraine rises dramatically during the college years (late teens to mid-
twenties; Lipton, Bigal, Hamelsky, & Scher, 2008). Further, at least two-thirds of college 
students report occasional sleep disturbances, and about one-third of these report severe sleep 
difficulties (Coren, 1994; Lack, 1986). The large majority of college students have moderate to 
severe sleep complaints, and only 11% of students report good sleep quality (Brown et al., 2002; 
Buboltz, Brown, & Soper, 2001). Because of the high prevalence of sleep problems among 
college students, their use as a sample for this study is of particular relevance. College life likely 
contributes to maladaptive sleep patterns, which in turn places students at risk for onset of 
migraine and subsequent disability (Brown et al., 2002; Rains & Poceta, 2006). In essence, the 
sleep disturbances that occur during the college years may function as etiological factors in the 
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subsequent development of migraine. The present study thus endeavored to identify problematic 
sleep behaviors and their association with migraine so as to inform the development and 
refinement of subsequent behavioral sleep interventions to reduce migraine frequency, intensity, 
and disability.  
 The following specific goals and hypotheses were proposed: 
Study Goal 1: To determine if migraineurs engage in poorer sleep hygiene than do 
nonmigraineurs. 
Hypothesis 1a: Poor sleep hygiene will differentiate migraineurs from controls. 
Hypothesis 1b: Migraineurs will engage in poorer sleep hygiene than nonmigraineurs 
even after controlling for comorbid depression/anxiety and/or insomnia symptoms. 
Study Goal 2: To identify specific patterns of problematic sleep hygiene behaviors that 
characterize migraineurs. 
Hypothesis 2: Migraineurs will differ from controls on specific sleep hygiene behaviors 
(e.g., not having a consistent sleep/wake schedule, more frequent napping, spending more 
time in bed, and going to bed physically or emotionally aroused).   
Study Goal 3: To determine if migraineurs’ poor sleep hygiene is predictive of migraine-related 
variables.   
Hypothesis 3: The severity of poor sleep hygiene will be a significant predictor of 
migraine frequency, migraine severity, and migraine-related disability.  
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Methods 
Participants 
Participants were undergraduate students at the University of Mississippi who received 
modest course credit for their participation. Participants included those who suffered from 
migraine headaches and healthy controls who did not suffer from any type of primary headache 
other than episodic tension-type headache. Participants who screened positive for migraine were 
administered a structured headache interview to confirm the migraine diagnosis. Those verified 
as migraineurs comprised the migraine group. Controls were those who denied experiencing 
problematic headaches. Assuming a small to moderate effect size (f2 = 0.08), a power level of 
0.80, and an alpha level of 0.05, a total sample size of 236 participants was required.  
Measures 
Demographic Questionnaire. The Demographic Questionnaire consisted of a number of 
questions that assess for basic information such as age and gender, and other more specific 
questions related to general disability and other headache/migraine variables and symptoms. This 
questionnaire can be found in Appendix A. 
ID Migraine. The ID Migraine (Lipton et al., 2003) is a three-item self-administered 
measure used to screen for migraine in the primary care setting. The three items assess for 
migraine-related disability and the symptoms of nausea and light sensitivity, which are uniquely 
characteristic of migraine. The endorsement of two or more items is considered a positive screen 
for migraine (Lipton et al., 2003). The ID Migraine is one of the briefest but most valid and 
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reliable screeners of migraine currently used in research. Construct validity of ID Migraine 
scores was established in the original study by comparing positive screens on the measure to 
migraine diagnoses made by headache specialists in a large primary care setting (Lipton et al., 
2003). Validity of ID Migraine scores was further established in a separate study by comparing 
the measure to the Brief Headache Screen (Maizels & Houle, 2007). The two measures showed 
82.6% agreement (kappa = 0.79). Criterion validity of the measure was also established in the 
original study. The final three items (out of nine original diagnostic screening questions) showed 
a sensitivity of 0.81 and a specificity of 0.75 (positive predictive value = 0.93). Test-retest 
reliability was also high (kappa = 0.68; Lipton et al., 2003). This measure can be found in 
Appendix B.  
Brief Headache Screen. The Brief Headache Screen (BHS; Maizels & Burchette, 2003) 
is a seven-item measure that was designed to screen for migraine and drug-rebound headache, as 
well as assess for satisfaction with current medication and desire for preventative medication. 
The diagnostic portion of the BHS consists of three questions specifically assessing the 
frequency of severe (disabling) headache, mild headache, and medication use. A score of 1-3 on 
the first and second items signifies episodic migraine. Four of the seven questions require the 
rater to rate each item on a four point Likert-type scale (0 = almost never, 4 = daily or near 
daily), while the other three questions require a yes or no response. As mentioned above, BHS 
scores showed high reliability and validity when compared to the ID Migraine (Maizels & 
Houle, 2007) and in the original study (93% specificity for migraine based on responses to 
Question 1; Maizels & Burchette, 2003). This measure can be found in Appendix C. 
Sleep Hygiene Index. The Sleep Hygiene Index (SHI; Mastin et al., 2006) is a 13-item 
self-report measure used to assess the presence of behaviors that comprise the criteria for ISH as 
	  18	  
classified by the ICSD-R (AASM, 2001). The SHI assesses how frequently the respondent 
engages in specific sleep behaviors, using a five point Likert-type scale ranging from always to 
never. Scores range from 13-65 with higher summed scores on the index indicating more 
maladaptive sleep behaviors. SHI scores have adequate test-retest reliability (r = 0.71) and 
internal consistency (α = 0.66) that is superior to that of scores of previously published sleep 
hygiene instruments (Mastin et al., 2006). SHI scores have shown good validity as evidenced by 
significant correlations (p < .01) with the Epworth Sleepiness Scale (r = 0.244; Johns, 1991) and 
the Pittsburgh Sleep Quality Index (r = 0.481; Buysse, Reynolds, Monk, Berman, & Kupfer, 
1988), indices that have shown to be related to the construct of sleep hygiene (Mastin, Peszka, 
Poling, Phillips, & Duke, 2005). The current study examined both the total SHI score as well as 
group differences on individual sleep behaviors (items). This measure can be found in Appendix 
D. 
Migraine Disability Assessment Questionnaire. The Migraine Disability Assessment 
Questionnaire (MIDAS; Stewart, Lipton, Dowson, & Sawyer, 2001) is a seven-item measure that 
assesses headache-related disability. The MIDAS requires the migraine sufferer to answer five 
questions, counting the number of days in the past three months that migraine has limited his/her 
activities at school/work, at home, and in social activities. The first five items are summed, 
resulting in a global disability score with scores 0-5 indicating little or no disability, 6-10 
indicating mild disability, 11-20 indicating moderate disability, and ≥ 21 indicating severe 
disability. The final two questions on the measure ask the individual to notate the frequency and 
intensity of his/her headaches. The internal consistency, test–retest reliability, and validity of 
MIDAS scores have been established in many different populations (α = 0.73-0.76; Stewart et 
al., 1999; Stewart, Lipton, & Sawyer, 1999). Validity of MIDAS scores was also established by 
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comparing the measure to a 90-day headache diary in migraineurs (Stewart et al., 2000) and by 
comparing the measure in migraineurs and controls (Bigal, Rapoport, Lipton, Tepper, & Sheftell, 
2003). This measure can be found in Appendix E. 
Headache Impact Test-6. The Headache Impact Test-6 (HIT-6; Kosinski et al., 2003) is 
a six-item self-report measure of headache-related disability. This measure requires the 
individual to rate each item on a five point Likert-type scale from never to always. Scores range 
from 36-78, with ≤ 49 characterized as little to no impact on life, 50-55 as some impact, 56-59 as 
substantial impact, and ≥ 60 as severe impact. HIT-6 scores have shown to be a reliable and valid 
measure of headache-related disability in the general population (with internal consistency = 
0.89, alternate forms reliability = 0.90, and test-retest reliability = 0.80; Kosinski et al., 2003) 
and in treatment-seeking individuals (α = 0.87; Kawata et al., 2005). This measure can be found 
in Appendix F. 
Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI; Buysse et 
al., 1988) is a 24-item measure that assesses sleep disturbance on seven dimensions: subjective 
sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of 
sleep medication, and daytime dysfunction (Buysse et al., 1988). Scores from these seven areas 
are summed resulting in a global score ranging from 0-21. Internal homogeneity, internal 
consistency, and test-retest reliability were established in the original study by Buysse et al. 
(1988) in a clinical sample of individuals with depression and sleep disorders. They found that 
global PSQI scores > 5 showed 89.6% sensitivity and 86.5% specificity for detecting “good” and 
“poor” sleepers. These statistics have since been replicated in a non-clinical sample of adults 
(Grandner, Kripke, Yoon, & Youngstedt, 2006) and insomniacs (sensitivity of 98.7, specificity 
of 84.4, and α = 0.85; Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002). This 
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measure can be found in Appendix G. 
Epworth Sleepiness Scale. The Epworth Sleepiness Scale (ESS; Johns, 1991) is a self-
administered eight-item measure of daytime sleepiness in adults. Respondents rate items 
pertaining to the likelihood of dozing during various activities on a four point Likert-type scale, 
ranging from 0 (would never doze) to 3 (high chance of dozing). Ratings on the ESS are summed 
with a score < 10 considered normal (although < 5 is desirable), 10-15 considered as moderate 
sleepiness, and 16-24 as severe sleepiness. The ESS is one of the most widely used paper-pencil 
measures of daytime sleepiness in adults (Rains & Poceta, 2006) and has been validated against 
polysomnographic recordings of an individual’s tendency to fall asleep (Johns, 1991). Reliability 
and internal consistency of ESS scores also has been established in a study comparing healthy 
medical students to individuals with obstructive sleep apnea (α = 0.88) (Johns, 1992). This 
measure can be found in Appendix H.	  
Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9; Spitzer, 
Kroenke, & Williams, 1999) is a self-administered measure of depression that is commonly used 
for the purpose of screening for depression among medical patients (Kroenke, Spitzer, & 
Williams, 2001). The PHQ-9 assesses the nine diagnostic criteria for a major depressive episode 
according to the Diagnostic and Statistical Manual of Mental Disorders (APA, 2000). Scores 
range from 0-27 with scores of 5, 10, 15, and 20 reflecting mild, moderate, moderately severe, 
and severe depression, respectively. The PHQ-9 is one of the most commonly used and validated 
brief measures of depression in use today among medical patients (Fann et al., 2005; Huang, 
Chung, Kroenke, Delucchi, & Spitzer, 2006; Kroenke & Spitzer, 2002; Lowe, Kroenke, Herzog, 
& Grafe, 2004; Martin, Rief, Klaiberg, & Braehler, 2006; Pinto-Meza, Serrano-Blanco, 
Penarrubia, Blanco, & Haro, 2005) and has strong psychometric properties. Construct validity 
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was established by comparing the PHQ-9 to the 20-item Short-Form General Health Survey, 
self-reported sick days and doctor’s visits, and symptom-related disability (Spitzer, William, & 
Kroenke, 2000). Criterion validity was established by comparing the PHQ-9 against an 
independently structured mental health professional interview in a sample of 580 people 
(Kroenke et al., 2001). Specifically, a PHQ-9 score ≥ 10 was shown to have a sensitivity of 88% 
and a specificity of 88% for identifying major depression (Kroenke et al., 2001). This measure 
can be found in Appendix I. 
GAD-7. The GAD-7 (Spitzer, Kroenke, Williams, & Lowe, 2006) is a self-report 
measure used to screen for Generalized Anxiety Disorder (GAD). The GAD-7 consists of seven 
items that reflect the DSM-IV-TR (APA, 2000) diagnostic criteria for Generalized Anxiety 
Disorder. Each item requires the respondent to indicate the frequency of each symptom over the 
past two weeks. Each item is rated on a 4-point Likert-type scale ranging from 0 (not at all) to 3 
(nearly every day). GAD-7 scores range from 0-21 with scores ≥ 5 indicating mild anxiety, 
scores ≥ 10 indicating moderate anxiety, and scores ≥ 15 indicating severe anxiety (Spitzer et al., 
2006). 
The GAD-7 is one of the most commonly used, easily accessible, and validated brief 
measures of anxiety used in medical research today (Hallgren & Morton, 2007; Lowe et al., 
2008). Initial use of the measure by Spitzer et al. (2006) showed that GAD-7 scores had excellent 
internal consistency (α = 0.92), test-retest (procedural) reliability (intraclass correlation = 0.83), 
good reliability and good criterion, construct, factorial, and procedural validity in primary care 
patients. Scores ≥ 10 also showed high sensitivity (89%) and specificity (82%) for diagnosing 
GAD (Spitzer et al., 2006). GAD-7 scores were also shown to be reliable and valid in a study of 
more than 5000 subjects in the general population (Lowe et al., 2008). Most recently, the GAD-7 
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has also been shown to be effective at detecting other anxiety disorders such as panic disorder, 
social phobia, and posttraumatic stress disorder (Kroenke, Spitzer, Williams, Monahan, & Lowe, 
2007). This measure can be found in Appendix J. 
Structured Diagnostic Interview for Headache – Revised (Brief Version). The 
Structured Diagnostic Interview for Headache-Revised (SDIH-R; Penzien, Bartley, Rhudy, & 
Rains, 2007) consists of 17 questions assessing migraine and contains appendices for assessing 
aura symptoms, cluster headache symptoms, medication over-use symptoms, and post-traumatic 
headache symptoms. The majority of questions assess migraine pain location, headache intensity, 
pain features, frequency, history, duration, and other migraine symptoms. Responses to this 
interview allow for determination of a migraine diagnosis based on criteria of the ICHD-II (IHS, 
2004). In the current study, migraine participants were defined as those who met ICHD-II 
diagnostic criteria for migraine (ICHD code 1.1), typical migraine with aura (1.2.1), or chronic 
migraine (1.5.1). This measure can be found in Appendix K. 
Procedures 
After providing written informed consent, participants completed a packet of 
questionnaires including the aforementioned measures. Those who screened positive for 
migraine based on their responses to the ID-Migraine were scheduled to meet individually with a 
trained headache researcher for administration of the SDIH-R, in order to confirm their 
diagnostic status. Those who met diagnostic criteria for migraine were assigned to the migraine 
group. Those denying problematic headaches on the demographic questionnaire, ID-Migraine, 
and Brief Headache Screen comprised the control group and were not administered the SDIH-R. 
Participants who screened positive for migraine on the ID-Migraine but did not meet diagnostic 
criteria for migraine based on the structured interview were assigned to the control group. 
	  23	  
(Although not a specific focus of this thesis, individuals who met diagnostic criteria for migraine 
were asked to engage in two weeks of self-monitoring of their sleep behaviors and migraine 
patterns as part of an ancillary study. Participants also completed a computerized pain attentional 
bias task as part of another ancillary study.) 
Statistical Analyses  
In order to test the main hypothesis, which sought to examine whether episodic 
migraineurs and controls differed on a global score of sleep hygiene, an independent samples t-
test was conducted. Subsequently, a series of univariate ANCOVAs were used to determine if 
the significant difference in global sleep hygiene persisted after individually controlling for 
symptoms of depression (PHQ-9), anxiety (GAD-7), and insomnia (PSQI and ESS). A 
MANOVA was conducted in order to test the second hypothesis, which sought to compare the 
groups on specific sleep hygiene behaviors as indexed by the 13 SHI items while controlling for 
family-wise Type I error rates given the number of dependent variables assessed. Univariate 
follow-up ANOVAs of individual items were conducted as appropriate. In addition to examining 
specific sleep hygiene behaviors, the current study also sought to predict migraine frequency, 
severity, and headache-related disability using global sleep hygiene scores. Linear regression 
analyses were conducted in order to determine the amount of variance predicted by global sleep 
hygiene in these migraine variables. To further explore psychological symptoms comorbid with 
migraine and sleep disturbance, a MANOVA was performed to determine if the groups differed 
on insomnia, anxiety, and depression, with follow-up univariate ANOVAs as appropriate. 
Finally, a chi-square analysis was conducted in order to determine if there were any clinically 
significant differences between groups on proportions with elevated scores on each 
psychological variable.  
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Results 
Participant Demographics and Migraine Prevalence 
 The sample consisted of 323 college students (70.9% female) with a mean age of 19.28 
years (SD = 3.38). The majority (62.8%) of the sample was Caucasian, 29.1% was African 
American, 3.1% was Asian, 0.9% was Hispanic/Latino, 1.2% was Native American/Pacific 
Islander, and 2.8% were of other ethnicities. With regard to migraine, 92 participants (28.5%) 
met ICHD-II diagnostic criteria for migraine: 84 (26%) with episodic migraine and eight (2.5%) 
with chronic migraine. Because the present study focused on episodic migraine, chronic 
migraineurs were excluded from subsequent analyses. Nearly three-quarters (73.8%) of episodic 
migraineurs were female, and 27.4% experienced aura. Average headache frequency for episodic 
migraineurs was 5.11 days/month (SD = 3.80). They reported an average headache-related 
disability score of 17.07 (SD = 19.15) on the MIDAS and an average score of 60.89 (SD = 5.09) 
on the HIT-6. Although half were classified as having minimal or mild migraine-related 
disability, 53% of episodic migraineurs endorsed moderate to severe disability on the MIDAS, 
compared to 84.3% endorsing substantial to severe impact on the HIT-6.  
Data Analytic Assumptions 
 Histograms, Q-Q plots, and descriptive statistics data (i.e., skewness, kurtosis) were used 
to assess data analytic assumptions for the main total scores of interest (SHI, ESS, PSQI, PHQ-9, 
GAD-7) to be compared between episodic migraineurs and controls and found satisfactory. 
Levene’s test of equality of error variances confirmed that homogeneity of variance was met for 
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all main criterion variables. Episodic migraineurs and control participants were then assessed for 
multivariate outliers on the main total scores of interest by group using Mahalanobis distance; 
one multivariate outlier was found using a conservative p < .001 cutoff (control participant) and 
was thus removed from subsequent analyses. 
Sleep Hygiene and Its Associations  
 Regarding sleep hygiene, over half of the entire sample (episodic migraineurs and 
controls) endorsed frequently or always engaging in poor sleep hygiene behaviors such as going 
to bed at different times each day (56.7%); doing something mentally stimulating before bedtime 
(58.9%); using the bed for things other than sleep and sex (61.8%); doing important work before 
bedtime (56.5%); and thinking, planning, or worrying when in bed (56.7%) (see Table 1). 
Episodic migraineurs obtained significantly higher total scores on the SHI than controls (M = 
38.24 [SD = 6.71] v. 36.54 [SD = 6.06], p < .05), indicating that they evidenced poorer overall 
sleep hygiene. After controlling for symptoms of insomnia, anxiety, and depression using 
separate ANCOVAs, however, these differences were rendered nonsignificant: PSQI overall 
model: F(1,284) = .076, p = .783, partial η2 = .000; ESS overall model: F(1,305) = 2.45, p = 
.119, partial η2 = .008; PHQ-9 overall model: F(1,311) = .116, p = .733, partial η2 = .000; GAD-
7 overall model: F(1,310) = .518, p = .472, partial η2 = .002. Notably, the corresponding 
covariate effect size values (η2) ranged from .093 (ESS) to .242 (PHQ-9); the effect size of 
insomnia as measured by the PSQI was higher than that of the ESS (.175 vs. .093, respectively).  
 The overall MANOVA comparing groups on the 13 SHI items was nonsignificant, 
F(13,295) = 1.076, p = .379, partial η2 = .045. Although the MANOVA was nonsignificant, 
because the overall sleep hygiene score differed significantly between the groups, an ANOVA 
was performed on individual items to aid in interpretation. Of all the items, only the variable of 
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“going to bed feeling stressed, angry, upset, or nervous” differed significantly between groups, 
F(1,312) = 6.46; p = .012, partial η2 = .020. However, applying a Bonferroni correction to this 
result (requiring a p < .004, given the non-significant MANOVA) would not retain statistical 
significance.  There was no difference in sleep hygiene between episodic migraineurs with and 
without aura (M = 39.00 [SD = 7.08] v. 36.22 [SD = 5.23], p = .09). 
Headache-Related Disability 
 Among episodic migraineurs, linear regression analyses confirmed that poorer sleep 
hygiene significantly predicted headache-related disability as measured by both the MIDAS and 
HIT-6, accounting for 11.0% and 7.7% of variance in headache disability, respectively (see 
Table 2). Despite its relationship with insomnia though, sleep hygiene did not predict migraine 
severity or frequency as obtained from SDIH-R responses. Insomnia (as measured by the PSQI), 
conversely, significantly predicted headache-related disability as measured by the MIDAS (R2 = 
18.2%) and HIT-6 (R2 = 6.8%), as well as migraine frequency (R2 = 14.8%), but not headache 
severity. No significant differences emerged between episodic migraineurs with and without aura 
in headache-related disability or migraine frequency or severity (see Table 3). 
Psychological Variables  
 Bivariate correlational analyses showed that global sleep hygiene scores were 
significantly correlated with psychological variables including insomnia (PSQI: r = .432, p < 
.001; ESS: r = .315, p < .001), depression (r = .503, p < .001), and anxiety (r = .447, p < .001) 
for the entire sample. In comparing episodic migraineurs and controls on these variables using a 
MANOVA, the Wilks’ lambda multivariate criterion for overall group differences was 
significant, F(4,276) = 7.756, p < .0001 (partial η2 = .101), indicating that episodic migraine and 
nonmigraine participants differed on the combination of variables relevant to the psychological 
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impact of migraine. No significant differences emerged between episodic migraineurs with and 
without aura on any of the assessed psychological variables (see Table 4). Subsequent univariate 
ANOVAs revealed that episodic migraineurs reported statistically higher levels of insomnia (as 
measured by the PSQI), depression, and anxiety than did controls (see Table 5). The difference 
between daytime sleepiness approached significance, though the majority of participants in both 
groups reported clinically significant elevations on this variable (ESS ≥ 10 indicating disordered 
sleep) (see Table 6).  
 Efforts to quantify clinically significant differences involved comparing the proportion of 
each group achieving an elevated score on the psychological variables of interest (i.e., PSQI > 5; 
ESS, PHQ-9, and GAD-7 ≥ 10). As is evident from Table 6, a large proportion of both groups 
endorsed clinically significant problems with sleep pertaining to daytime sleepiness (44.8% of 
sample) and insomnia (68.3% of sample), as well as elevated levels of depression (25.5%) and 
anxiety (23.0%). However, a significantly higher proportion of migraineurs than controls 
achieved clinically significant elevations on insomnia, depression, and anxiety scores. No 
differences in daytime sleepiness were observed, consistent with results of nonsignificant 
findings on the univariate ANOVA between groups. 
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Discussion 
 The present study sought to identify associations between problematic sleep hygiene 
behaviors and episodic migraine so as to inform the development and refinement of subsequent 
behavioral sleep interventions to reduce migraine symptomatology. The present study also 
explored psychological disorders such as anxiety and depression and their relation to migraine, 
sleep hygiene, and insomnia in college students, a population of interest because of their high 
rates of migraine (Bigal et al., 2001; Lipton et al., 2008), sleep disturbances (Brown et al., 2002; 
Coren, 1994; Lack, 1986), and psychological comorbidities (Kessler et al., 2005; Smitherman, 
McDermott, & Buchanan, 2011). Conclusions from the current study are strengthened by the fact 
that many of our observations were consistent with previous studies on this population of 
interest. 
First, the observed prevalence of episodic migraine was consistent with previous studies 
on college students. The current study observed a prevalence of 28.5% while both Bigal et al. 
(2001) and Smitherman et al. (2011) observed a prevalence approximating 25%. Secondly, the 
observed prevalence of sleep disturbance was also consistent with previous studies among this 
population (Buboltz et al., 2001). In the current study, 68.3% of the total sample (85.9% of 
migraineurs, 61.7% of controls) reported poor sleep quality (PSQI > 5), while 73% of students in 
the study by Buboltz et al. endorsed at least occasional sleep problems. More direct comparisons 
between these two studies are difficult because different measures of sleep quality were used. 
Rates of elevated psychological symptomatology among college migraineurs were generally 
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consistent with, though slightly higher than, those observed in previous studies. For instance, in 
the current study significant symptoms of depression and anxiety were reported by 39.3% and 
34.5% of migraineurs, respectively, compared to 27.2% and 23.9% of migraineurs, respectively 
in Smitherman et al. In addition, Kessler et al. (2005) reported the lifetime of prevalence of 
experiencing an anxiety or mood disorder between the ages of 18 and 29 to be 21.4% 
(depression) and 30.2% (anxiety). Finally, the presence of episodic migraine was associated with 
significant headache-related disability for a sizeable proportion of participants, although mean 
disability scores were higher than those from previous studies (Smitherman et al.).  
Sleep Hygiene 
 As was the main focus of this study, sleep hygiene was found to be poorer among 
migraineurs than controls. This is consistent with previous findings by Calhoun et al. (2006) and 
Bruni et al. (1997, 1999) that migraineurs consistently engage in behaviors that are 
nonconducive to sleep, such as watching TV or reading in bed (78.9% of migraineurs); eating or 
drinking prior to bedtime (70.1%); taking naps (63.3%); spending too much or little time in bed 
(37%); and having more variable sleep/wake schedules. Although insomnia symptoms and poor 
sleep hygiene were more prevalent in the migraine group, only one sleep hygiene variable, going 
to bed feeling stressed, angry, upset, or nervous, was different between the migraine and control 
groups. However, because the overall analysis of sleep hygiene items was nonsignificant, and 
because this finding was nonsignificant after Bonferroni correction, the single item is likely not 
of particular importance in informing the current study. Despite research from previous studies 
indicating that both adolescent migraineurs (Bruni et al.) and women with transformed migraine 
(Calhoun et al.) exhibit poor sleep hygiene behaviors (e.g., frequent napping, variable sleep/wake 
schedules), the current study did not reflect these previously-reported group differences.  
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 Our adherence to the a priori sample size calculation rules out inadequate sample size as 
a contributing factor to the null differences on multiple sleep hygiene components. One 
explanation for the present results is that the control group also exhibited poor sleep habits 
(Buboltz et al., 2001; Coren, 1994). This argument is supported by the finding that over half of 
the student sample endorsed frequently or always going to bed at different times from day to day; 
doing something mentally stimulating or important work before bedtime; using the bed for things 
other than sleep and sex; and thinking, planning, or worrying in bed. A large proportion of both 
groups also endorsed clinically significant sleep problems pertaining to insomnia and daytime 
sleepiness, and thus any potential differences might be better elucidated using a control group 
with less disturbed sleep. However, another possible explanation for our failure to observe group 
differences is that sleep hygiene behaviors are not as important among episodic migraineurs as 
they are among chronic migraineurs. Kelman and Rains (2005) found that chronic migraineurs 
reported shorter sleep episodes and were more likely to complain of difficulty falling asleep than 
were episodic migraineurs. Ohayon (2005) also described a strong relationship between sleep 
difficulties and chronic headaches as did Calhoun et al. (2006), who found that 83.7% of chronic 
migraineurs stated that they usually awakened tired compared to only 38.1% of episodic 
migraineurs. Considering our null findings in conjunction with existing studies of adults with 
chronic migraine, the role of poor sleep hygiene does not appear to be as strong among episodic 
migraineurs. However, future studies are warranted to confirm this latter hypothesis. 
Comorbid Psychological Symptoms 
 Although migraineurs and controls differed on a score of global sleep hygiene, this 
difference was attributable principally to differences in co-occurring symptoms of insomnia, 
anxiety, and depression. Consistent with numerous previous studies (Lanteri-Minet et al., 2005; 
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Oedegaard et al., 2006; Paiva et al., 1994; Rains & Poceta, 2006; Smitherman et al., 2011), 
episodic migraineurs reported greater symptoms of depression, anxiety, and insomnia than did 
nonmigraineurs. However, our results are contrary to those of Vgontzas et al. (2008), who found 
that sleep disturbance persisted even after controlling for depression and anxiety disorders. The 
results of the aforementioned study and the current study likely conflict because Vgontzas et al. 
controlled for lifetime and current rates of all anxiety disorders (instead of GAD symptoms 
only). They also compared migraineurs and nonmigraineurs on more general sleep complaints, 
such as difficulty falling and staying asleep, instead of specific sleep hygiene behaviors, as did 
the current study. Again, these findings strengthen the idea that, although closely related (Buysse 
et al., 1994), general symptoms of insomnia have a greater influence on migraine and comorbid 
psychological disorders than do sleep hygiene behaviors in isolation.  
Treatment Implications of the Current Study  
 Although directly modifying sleep hygiene behaviors has shown promise in treating 
chronic migraine (Calhoun & Ford, 2007), sleep hygiene treatment is not usually offered in 
isolation for insomnia specifically because its effects on insomnia are less potent than those of 
stimulus control and sleep restriction, as confirmed by systematic reviews (Morin et al., 2006), 
practice parameters (Morganthaler et al., 2006), and clinical guidelines (Schutte-Rodin et al., 
2008). Another reason that sleep hygiene treatment is not often offered in isolation is because 
sleep hygiene only targets specific sleep habits and does not address other factors that contribute 
to insomnia (e.g., environmental cue stimuli, psychological comorbidities). As such, broad-based 
insomnia treatment packages tend to include modifying sleep behaviors, restricting sleep, and 
altering environmental stimuli, as well as directly targeting other psychological symptoms 
related to comorbid depression and anxiety.  
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 Based on the current findings that poorer sleep hygiene and insomnia symptoms 
significantly predicted migraine-related disability, a rigorous sleep hygiene protocol might 
beneficially impact headache-related disability among episodic migraineurs; however, this notion 
awaits empirical verification. Although the present study did not find associations between sleep 
hygiene and migraine frequency or severity, previous research has indicated that various sleep 
disturbances (e.g., hypnic jerks, nightmares) are related to headache severity (Bruni et al., 1999). 
In light of this evidence and the potency of more comprehensive sleep interventions, perhaps the 
most effective means of improving sleep and migraine is a treatment package that addresses 
insomnia symptoms (i.e., sleep restriction, stimulus control), modifies sleep hygiene behaviors, 
and manages comorbid psychological symptoms (Edinger et al., 2009; Friedman et al., 2000; 
Scholcket et al., 1988; Vincent & Lewycky, 2009). 
Limitations and Future Directions 
 While this study is unique because of its large sample size, focus on episodic 
migraineurs, and adherence to ICHD-II diagnostic criteria, limitations exist. One limitation of 
this study is that alcohol use/abuse was not assessed, despite the fact that it is often comorbid 
with and influences sleep problems (Johnson & Breslau, 2001) and is disproportionately 
prevalent among college populations (O’Malley & Johnston, 2002). Another limitation is 
reliance on survey-based instruments to assess the sleep and psychological variables. While 
adherence to a structured diagnostic headache interview and ICHD-II diagnostic criteria are 
strengths of the headache data, daily diary data on sleep and structured interview diagnoses of 
affective disorders would have further strengthened the present study. The aforementioned 
ancillary study will use self-monitoring data to extend the present findings and test additional 
hypotheses related to sleep disturbance and migraine using time-series analyses.  
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 As mentioned above, studies are needed comparing the role of sleep hygiene (versus 
other insomnia variables) in episodic and chronic migraineurs, and in validating the efficacy of 
more broad-based sleep interventions among episodic migraineurs with comorbid psychological 
disorders. In light of limitations of the present study, future studies should assess relations 
between alcohol use and insomnia/sleep hygiene among college migraineurs. Such studies could 
use a design similar to the present study but with the addition of prospective self-monitoring data 
for alcohol, sleep, and migraine variables and in using interactions between alcohol and sleep to 
predict headache occurrence and disability. Given the significant headache-related disability 
observed among this sample, broad-based university education and intervention efforts should 
focus on identifying college migraineurs with significant headache-related disability and offering 
validated pharmacological or behavioral migraine interventions.  
 Although a large proportion of treatment studies have focused on chronic migraineurs, 
outcome studies should explore means of targeting headache-related disability among episodic 
migraineurs given their evidenced high rates of functional impairment. Specifically, treatment 
studies could focus on assessing and comparing the efficacy of sleep hygiene interventions that 
have shown promise with chronic migraineurs (Calhoun & Ford, 2007) with more 
comprehensive sleep modification interventions that have strong research support for insomnia 
more broadly (e.g., stimulus control and sleep restriction). Although there is evidence for the 
efficacy of these treatments, the exact mechanisms of action still remain largely unclear, 
particularly as they relate to beneficial impact on migraine symptoms. Dismantling studies are 
warranted to determine the most essential therapeutic mechanisms that underlie improvements in 
migraine stemming from improvements in sleep. Furthermore, given the paucity of data 
regarding the effects of treating comorbid psychological disorders on migraine, a strong need 
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remains for treatment studies that assess the effects of treating comorbid depression or anxiety on 
both sleep and headache symptoms. Because availability of effective behavioral therapies 
remains a barrier to broader treatment access, further research is needed also on promoting 
dissemination of empirically-supported behavioral interventions, which are both efficacious 
(Rains, Penzien, McCrory, & Gray, 2005) and cost-effective (Schafer et al., 2011) in comparison 
to pharmacologic management. Cumulatively, such studies will help further the growing 
literature pertaining to the role of sleep and related variables in perpetuating migraine.  
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Table 1 
Group Differences on Sleep Hygiene Index Items 
 Episodic 
Migraineurs 
M (SD) 
Controls 
M (SD) 
P 
value 
 
% of controls 
endorsing 
frequently or 
always 
% of 
migraineurs 
endorsing 
frequently or 
always 
P value 
1. I take daytime 
naps lasting two or 
more hours. 
2.75 (1.02) 2.52 (1.07) .088 18.26 25.00 .281 
2. I go to bed at 
different times from 
day to day. 
3.68 (1.08) 3.57 (1.04) .443 55.65 59.52 .803 
3. I get out of bed at 
different times from 
day to day. 
3.02 (1.25) 2.92 (1.10) .469 30.57 38.10 .254 
4. I exercise to the 
point of sweating 
within one hour of 
bedtime. 
1.73 (0.87) 1.72 (0.81) .934  3.49  2.38 .077 
5. I stay in bed 
longer than I 
should two or three 
times a week. 
2.76 (1.19) 2.49 (1.14) .064 21.93 26.19 .209 
6. I use alcohol, 
tobacco, or caffeine 
within four hours of 
going to bed or 
after going to bed. 
2.37 (1.31) 2.12 (1.14) .091 14.35 19.05 .083 
7. I do something 
that may wake me 
up before bedtime 
(e.g., watch TV, 
read, eat, or study). 
3.55 (1.12) 3.60 (1.09) .746 58.26 60.71 .353 
8. I go to bed feeling 
stressed, angry, 
upset, or nervous. 
3.02 (0.93) 2.71 (0.97)  .012* 19.57 23.81    .010** 
9. I use my bed for 
things other than 
sleeping or sex (e.g., 
watch TV, read, 
eat, or study). 
3.63 (1.06) 3.57 (1.28) .830 63.04 58.33  .037* 
10. I sleep on an 
uncomfortable bed 
(e.g., poor mattress 
or pillow, too many 
or not enough 
blankets). 
2.13 (1.19) 2.00 (1.10) .329 12.17 15.48 .876 
11. I sleep in an 2.42 (1.16) 2.19 (1.16) .150 14.35 21.43 .137 
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* p < .05. ** p < .01 
11. I sleep in an 
uncomfortable 
bedroom (e.g., too 
bright, too stuffy, 
too hot, too cold, 
too noisy). 
2.42 (1.16) 2.19 (1.16) .150 14.35 21.43 .137 
12. I do important 
work before 
bedtime (e.g., pay 
bills, schedule, or 
study). 
3.55 (0.97) 3.60 (0.96) .722 57.21 54.76 .987 
13. I think, plan, or 
worry when I am in 
bed. 
3.63 (1.08) 3.56 (1.08) .517 55.65 59.52 .978 
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Table 2 
Sleep Hygiene and Insomnia as Predictors of Migraine Variables  
 
 Sleep hygiene as predictor Insomnia (PSQI) as predictor 
	   F value	   P value	   R2	   F value	   P value	   R2	  
MIDAS	   10.02	       .002**	   .110	   16.65	       .000**	   .182	  
HIT-6	    6.71	     .011*	   .077	    5.47	     .022*	   .068	  
Severity	    1.52	   .221	   .018	    1.41	   .239	   .018	  
Frequency	    1.00	   .320	   .013	   12.50	       .001**	   .148	  
 
* p < .05. ** p < .01 
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Table 3 
Differences on Migraine Variables Between Migraineurs With and Without Aura 
 
 Migraineurs without aura 
M (SD) 
N = 61 
Migraineurs with aura 
M (SD) 
N = 23 
P value 
HIT-6	                    60.28 (4.59)	               62.48 (6.02)	   .078	  
MIDAS	                    16.50 (19.05)	               18.54 (19.78)	   .666	  
Frequency	                      5.16 (3.95)	                 4.98 (3.46)	   .853	  
Severity	                      6.62 (1.40)	                 7.13 (2.58)	   .243	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Table 4 
Differences on Psychological Variables Between Migraineurs With and Without Aura  
 
 Migraineurs without aura 
M (SD) 
N = 61  
Migraineurs with aura 
M (SD) 
N = 23 
P value 
PSQI (insomnia)	                      8.89 (3.65)	   8.90 (2.63)	   .991	  
GAD-7 (anxiety)	                      7.87 (5.05)	   7.78 (4.23)	   .942	  
PHQ-9 (depression)	                      8.46 (5.08)	   9.00 (4.63)	   .657	  
ESS (insomnia)	                    10.44 (3.10)	   9.30 (4.42)	   .192	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Table 5 
Group Differences on Psychological Variables  
 
 Episodic Migraineurs  
M (SD) 
Controls 
M (SD) 
F Value P Value partial η2 
ESS (insomnia)           10.12 (3.53) 9.19 (3.79)       3.77    .053 .012 
PSQI (insomnia)             8.90 (3.39) 6.60 (3.05)     30.23 .000** .096 
PHQ-9 (depression)             8.61 (4.94) 6.39 (4.57)     13.85 .000** .043 
GAD-7 (anxiety)             7.85 (4.81) 5.76 (4.75)     11.72 .001** .036 
 
* p < .05. ** p < .01 
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Table 6 
 
Percent of Sample Reaching Clinical Significance on Psychological Variables 
 
 % of episodic migraineurs 
reaching clinical significance 
% of controls reaching 
clinical significance 
P Value 
of Chi-square 
ESS (insomnia) 54.9 41.2 .287 
PSQI (insomnia) 85.9 61.7    .001** 
PHQ-9 (depression) 39.3 20.4    .001** 
GAD-7 (anxiety) 34.5 18.8  .044* 
 
* p < .05. ** p < .01 
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Demographic	  Questionnaire	  
    
Age: ___________ 
 
Gender (circle one): Male        Female       Transgender     
 
Race (circle one): Caucasian African American        Asian        Hispanic/Latino 
 
Native American/Pacific Islander Other: ______________ 
 
What is your approximate height and weight?   _______ inches _____ pounds 
 
Do you snore (check one)? _____ Usually  ____ Sometimes _____ No 
 
Have a doctor ever diagnosed you with migraines? _____Yes _____No 
 
What year of school are you currently in (circle one)? 
 
Freshman Sophomore   Junior Senior         Graduate Student  N/A 
 
 
 
In the past 3 months, how many days of school have you missed?  
_____ days  
 
In the past 3 months, how many days were you unable to carry on your usual function at home?  
_____ days 
 
In the past 3 months, about how many medical visits have you made (include visits to your 
regular doctor, specialists, and Urgent Care or Emergency room)? 
_____ visits 
 
In the past 3 months, how many days did your health interfere with your ability to study? 
_____ days 
 
 
 
Have you had one or more problem headaches within the past year (Do NOT count 
headaches occurring during a hangover or sinus infection)? 
 
 _____Yes  _____No 
 
If YES, how many of these headaches do you have per month, on average? 
  
______ headaches per month 
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On average how severe are these headaches (circle one number)? 
 
   0      1     2     3     4     5     6     7     8     9     10 
  No                         Mild                  Moderate                   Very            Extremely 
 Pain                     Pain   Pain         Painful             Painful  
 
 
 
Which of the following that are typical features of these headaches (check all that apply)? 
 
_____ Occurs on one side of head 
 
_____ Pulsing/throbbing pain 
 
_____ Nausea or vomiting 
 
_____ Sensitivity to light 
 
_____ Sensitivity to sound 
 
_____  Visual or sensory symptoms that occur BEFORE the headache begins 
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ID	  Migraine 
 
Check one answer for each question below. 
 
1. Has a headache limited your activities for a day or more in the last three months? 
 
_____ Yes  _____ No 
 
2. Are you nauseated or sick to your stomach when you have a headache? 
 
_____ Yes  _____ No 
 
3. Does light bother you when you have a headache? 
 
_____ Yes  _____ No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From Lipton et al., 2003, in the public domain. 
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Brief Headache Screen 
Please answer the following questions about your headaches. Check the best answer for each 
question below. 
 
1. How often do you get severe headaches (difficult or unable to continue normal function)? 
 
_____ Daily or near daily 
_____ 3-4 days per week 
 _____ Between 2 days per week and 2 days per month 
 _____ Once a month or less 
 _____ Almost never 
 
2. How often do you get mild or less severe headaches?  
 
_____ Daily or near daily 
_____ 3-4 days per week 
 _____ Between 2 days per week and 2 days per month 
 _____ Once a month or less 
 _____ Almost never 
 
3. How often do you take pain relievers, or any medication to relieve headache symptoms?  
 
_____ Daily or near daily 
_____ 3-4 days per week 
 _____ Between 2 days per week and 2 days per month 
 _____ Once a month or less 
 _____ Almost never 
 
4. How often do you miss some work or leisure time because of headache?  
 
_____ Daily or near daily 
_____ 3-4 days per week 
 _____ Between 2 days per week and 2 days per month 
 _____ Once a month or less 
 _____ Almost never 
 
5. Are you satisfied with the current medication you use to relieve your headaches? 
 
_____ Yes _____ No 
 
6. Are you taking daily prescription medication to prevent headaches? 
 
_____ Yes _____ No 
 
7. If no, do your headaches trouble you enough to take daily preventive medication? 
 
_____ Yes _____ No 
 
 
Maizels & Burchette, 2003. Reprinted with permission.
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Sleep Hygiene Index 
Indicate how frequently you engage in each of the following behaviors. 
1=Never      2=Rarely      3=Sometimes    4=Frequently     5=Always 
 
1.  I take daytime naps lasting two or more hours. 
1  2  3  4  5 
 
2.  I go to bed at different times from day to day. 
1  2  3  4  5 
 
3.  I get out of bed at different times from day to day. 
1  2  3  4  5 
 
4.  I exercise to the point of sweating within 1 hour of going to bed. 
1  2  3  4  5 
 
5.  I stay in bed longer than I should two or three times a week. 
1  2  3  4  5 
 
6.  I use alcohol, tobacco, or caffeine within 4 hours of going to bed or after going to bed. 
1  2  3  4  5 
 
7.  I do something that may wake me up before bedtime (for example: play video games, use the internet,  
     or clean). 
1  2  3  4  5 
 
8.  I go to bed feeling stressed, angry, upset, or nervous. 
1  2  3  4  5 
 
9.  I use my bed for things other than sleeping or sex (for example: watch television, read, eat, or study). 
1  2  3  4  5 
 
10. I sleep on an uncomfortable bed (for example: poor mattress or pillow, too much or not enough  
      blankets). 
1  2  3  4  5 
 
11. I sleep in an uncomfortable bedroom (for example: too bright, too stuffy, too hot, too cold, or too  
      noisy). 
1  2  3  4  5 
 
12.  I do important work before bedtime (for example: pay bills, schedule, or study). 
1  2  3  4  5 
 
13.  I think, plan, or worry when I am in bed.  
1  2  3  4  5 
 
 
Mastin, Bryson, & Corwyn, 2006, Reprinted with permission 
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MIDAS 
 
Please answer the following questions about ALL your headaches you have had over the 
last 3 months. Write in your answer for each question below. 
 
1. On how many days in the last 3 months did you miss work or school because of your 
headaches?    
 
__________ days 
2. How many days in the last 3 months was your productivity at work or school reduced 
by half or more because of your headaches?  
(Do not include days you counted in question 1 where you missed work or school.)  
 
__________ days 
3. On how many days in the last 3 months did you NOT do household work because of 
your headaches?  
 
__________ days 
4. How many days in the last 3 months was your productivity in household work 
reduced by half of more because of your headaches?  
(Do not include days you counted in question 3 where you did not do household work.)  
 
__________ days 
5. On how many days in the last 3 months did you miss family, social or leisure 
activities because of your headaches?  
 
__________ days 
6. On how many days in the last 3 months did you have any headache?  
(If a headache lasted more than 1 day, count each day)  
 
__________ days 
7. On a scale of 0 - 10, on average how painful were these headaches?  
(where 0 = no pain at all and 10 = pain as bad as it can be)  
 
__________ days 
 
Lipton et al., 2003, and Stewart et al., 1999, 2003, Reprinted with permission 	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HIT-6 
 
 
This questionnaire was designed to help you describe and communicate the way you feel 
and what you cannot do because of headaches. 
 
To complete, please circle one answer for each question. 
 
 
1) When you have headaches, how often is the pain severe? 
 
    Never      Rarely      Sometimes         Very      Often      Always 
 
2) How often do headaches limit your ability to do usual daily activities including household      
    work, work, school, or social activities? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
3) When you have a headache, how often do you wish you could lie down? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
4) In the past 4 weeks, how often have you felt too tired to do work or daily activities because of  
    your headaches? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
5) In the past 4 weeks, how often have you felt fed up or irritated because of your headaches? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
6) In the past 4 weeks, how often did headaches limit your ability to concentrate on work or daily  
    activities? 
 
    Never      Rarely      Sometimes          Very      Often      Always 
 
 
 
 
 
 
 
 
 
 
 
From Kosinski et al., 2003, in the public domain. 
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From Buysse et al., 1988, in the public domain. 
   
Pittsburgh Sleep Quality Index (PSQI) 
 
 
      Instructions: The following questions relate to your usual sleep habits during the past month only. Your answers  
      should indicate the most accurate reply for the majority of days and nights in the past month. Please answer          
      all questions.   
 
      1. During the past month, what time have you usually gone to bed at night? ___________________  
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each night? __________ 
3. During the past month, what time have you usually gotten up in the morning?  ___________________  
4. During the past month, how many hours of actual sleep did you get at night? (This may be different than the 
number of hours you spent in bed.) ___________________  
 
5. During the past month, how often have you had  Not during  Less than  Once or  Three or more 
trouble sleeping because you…  the past  once a  twice a   times a week 
 month  week week   
a.  Cannot get to sleep within 30 minutes      
b.  Wake up in the middle of the night or early 
     morning    
    
c.  Have to get up to use the bathroom      
d.  Cannot breathe comfortably      
e.  Cough or snore loudly      
f.   Feel too cold      
g.  Feel too hot      
h.  Have bad dreams      
i.   Have pain      
j.   Other reason(s), please describe:     
     
     
6. During the past month, how often have you 
taken medicine to help you sleep (prescribed or 
“over the counter”)?   
    
7. During the past month, how often have you had      
trouble staying awake while driving, eating meals, 
or engaging in social activity? 
    
 No Only a Somewhat A very big 
 problem very slight of a problem 
 at all problem problem  
8. During the past month, how much of a problem 
has it been for you to keep up enough enthusiasm 
to get things done?                 
    
 Very  Fairly  Fairly  Very 
 good good bad bad 
9.  During the past month, how would you rate 
your sleep quality overall? 
    
     
 
 
Name:__________________________________________                         Date: ________________ 
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Epworth Sleepiness Scale 
How likely are you to doze off or fall asleep in the following situations, in contrast to just feeling 
tired? 
 
These questions are about your usual way of life in recent times. Even if you have not 
done some of these things recently, try to work out how they would have affected you. 
Use the following scale to choose the most appropriate number for each situation: 
0 - Would never doze 
1 - Slight chance of dozing 
2 - Moderate chance of dozing 
3 - High chance of dozing 
 
Activity & Chance of Dozing 
Sitting and reading      _____ 
Watching TV        _____ 
Sitting inactive in a public place (meeting, theater, etc)  _____ 
As a passenger in a car for 1 hour without a break   _____ 
Lying down in the afternoon when circumstances permit  _____ 
Sitting and talking to someone     _____ 
Sitting quietly after lunch without alcohol    _____ 
In a car, while stopped for a few minutes in traffic   _____ 
 
   Total _____ 
 
 
Epworth sleepiness scale. Each question is answered with a number from 0 (not at all 
likely to fall asleep) to 3 (very likely to fall asleep). This yields a total of 0 (minimum) to 
24 (maximum). Scores above 10 warrant investigation. 
 
SOURCE: JOHNS MW. A NEW METHOD OF MEASURING SLEEPINESS: THE EPWORTH 
SLEEPINESS SCALE. SLEEP 1991; 14:540-54 
 
 
 
 
 
From Johns, 1991, in the public domain. 
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PHQ-9 
 
Over the last two weeks, how often have you been bothered by any of the following problems:  
(circle the number that applies to you) 
 
 
Not at 
all 
 
Several 
days 
More 
than 
half the 
days 
Nearly 
every day 
1. Little interest or pleasure in doing things
  0 1 2 3 
2. Feeling down, depressed, or hopeless
  0 1 2 3 
3. Trouble falling or staying asleep, or 
sleeping too much 0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself—or that you 
are a failure or have let yourself or your 
family down 
0 1 2 3 
7. Trouble concentrating on things, such as 
reading the newspaper or watching 
television 
0 1 2 3 
8. Moving or speaking so slowly that other 
people could have noticed. Or the 
opposite—being so fidgety or restless that 
you have been moving around a lot more 
than usual 
0 1 2 3 
9. Thoughts that you would be better off 
dead, or of hurting yourself in some way 0 1 2 3 
If you checked off any problems, how 
difficult have these problems made it for 
you to do your work, take care of things at 
home, or get along with other people? 
Not 
difficult 
at all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
Difficult 
Total (For health professionals only) = 
_____ 
 
PHQ-9 is adapted from PRIME-MD®, which is a trademark of Pfizer Inc. Copyright © 1999 Pfizer Inc. Reproduced with permission.  
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GAD-7 
 
Over the last two weeks, how often have you been bothered by the following problems: (circle 
the number that applies to you) 
 
 
 
Not at 
all 
 
Several 
days 
More 
than half 
the days 
Nearly 
every day 
1. Feeling nervous, anxious or on edge
  0 1 2 3 
2. Not being able to stop or control 
worrying  0 1 2 3 
3. Worrying too much about different 
things 0 1 2 3 
4. Trouble relaxing  0 1 2 3 
5. Being so restless that it is hard to sit 
still 0 1 2 3 
6. Becoming easily annoyed or irritable
  0 1 2 3 
7. Feeling afraid as if something awful 
might  
    happen 
0 1 2 3 
If you checked off any problems, how 
difficult have these problems made it for 
you to do your work, take care of things 
at home, or get along with other people? 
Not 
difficult 
at all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
Difficult 
Total (For health professionals only) =  
_____ 
 
GAD-7 is from Spitzer, Kroenke, Williams, & Lowe, 2006. Copyright © 2006 Pfizer Inc. Reproduced with permission.	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Structured Diagnostic Interview for Headache –  
Revised (Brief Version) 	  	  
Patient Name: Age:  Sex:     M         F 
 
Patient ID: Interviewer:  Date:        /       / 	  	  
The following items are selected from the long version of the Structured Diagnostic Interview for Headache 
(SDIH). The SDIH is part of the Headache Evaluation and Diagnostic System (HEDS) which includes software 
for data entry and diagnostic decision-making. These materials are intended to facilitate diagnosis of selected 
recurrent, benign headaches according to both IHS (2004) and Ad Hoc Committee (1962) diagnostic criteria. 
Optimal use of this interview requires expertise with the diagnostic classifications and familiarity with the 
computer software and manual that accompany the interview. 	  	  
  1. Does the patient get more than one type of headache?  	   	  Yes  	    No 
 (Complete a separate brief interview form for each type of headache)       Headache   #1   #2   #3 
 
  2. Select all pain locations that apply to this type of headache: (You must check at least one) 
 
       	  frontal (A)    	    temporal (B)    	  occipital (C)    	  orbital (D)    	   	  supraorbital (E) 
 
  3. Select all that apply:  	    top of head (F)    	    base of neck (G)     	  nasal/facial (H) 	  
	  	  	  	   4. What is the intensity of pain that the patient experiences with a typical headache?   ____ (Indicate rating from 0-10) 	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  5. Which of the following symptoms are a “predominant feature” of this headache type (presume that the headache 
is untreated)? 
   
  Pain Location (Select only one):  Unilateral  	    Not Unilateral    
 
  Pain Features (Select only one):  Pulsating  	    Pressing/Tightening (non-pulsating)  	    Other: 
      
 
  6. How often does the patient experience this type of headache pain?   ____ d w m y (Indicate frequency in x per day, 
week, month,  
 or year) 
 
  7. How long have these headaches been occurring at this rate?   ____ Months  Years 
 
  8. What is the total number of this type of headache ever experienced:  	    1  	    2-4  	  5-9  	    >10  ____ 
(Indicate total number experienced) 
 
  9. How long does this headache last if untreated or unsuccessfully treated? (If patient falls asleep and wakes up 
without headache, duration of attack is until waking up. Check unremitting if patient reports never 
experiencing headache less than 7 days in duration). (Indicate duration in minutes, hours, or days)  
 
 	  Unremitting  OR 
 
 ____ m h d  Typical Average               ____ m h d  Typical Minimum               ____ m h d  Typical Maximum 
 
10. Has anything about this headache (except freq.) changed in the last 6 months?   	  Yes  	    No 
 If YES, explain:              
              
 
11. Is the patient’s typical headache pain aggravated by routine physical activities (i.e., walking, lifting, bending, etc.)?  	  Yes  	  No 
       
12. Do any of the following symptoms occur with this headache?  
 	  Loss of appetite/Anorexia 	  Headache worsened by conversational noise levels (phonophobia) 	  Headache worsened by normal light (photophobia) 	  Nausea (Indicate intensity) 	  Mild   	  Moderate   	  Severe                 	  Vomiting (Indicate intensity)  	  Mild   	  Moderate   	  Severe                   
   
13. Does the patient ever experience symptoms before this headache pain begins?   	  Yes   	  No 
If YES, and if any of the reported symptoms provide evidence of focal cerebral cortical, and/or brainstem                   
dysfunction, complete Appendix 1 
If NO, skip to #14 
 
14. Does this headache have severe unilateral orbital, supraorbital, and/or temporal pain, and/or does the interviewer 
suspect a cluster-type headache?  	  Yes   	  No 
 If YES, complete Appendix 2 
 If NO, skip to #15 
 
15. Does the patient use any medications to relieve headache pain?   	  Yes   	  No 
  If YES, complete #15a, #15b, #15c 
  If NO, skip to #16 
 
 15a. How long has the patient been using the medication(s) to relieve headache pain?   ____ d w m y (Indicate 
duration in days,   weeks, months, or years) 
 
 15b. What is the frequency of medication use?   ____ days per week    ____ days per month    ____ times per 
day 
 
 15c. Did this headache develop or markedly worsen during medication overuse?   	  Yes   	  No 
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 If YES, complete Appendix 3 
If NO, skip to #16  
 
16. Is this headache related to any head injury or trauma?   	  Yes   	  No 
 If YES, complete Appendix 4 
 If NO, skip to #17 
 
17. Is this headache suspected to be attributed to a physical or other neurological disorder?   	  Yes   	  No 
 
APPENDIX 1 Migraine Aura Symptoms 	  
 
1. How many aura attacks has the patient experienced? ____ 
 
2. What best describes the aura symptoms? (Select all that apply) 	  At least one aura symptom develops gradually over more than 4 minutes, AND/OR 2 or more 
symptoms  
     occur in succession over 4 minutes 	  Each aura symptom lasts longer than 4 minutes but less than 60 minutes 	   Headache begins during aura OR follows aura with a headache-free interval of less than 60 
minutes 
 
3. Indicate which of the following aura symptoms are present during this type of headache: (Select all that 
apply) 	  
 X SYMPTOM  X SYMPTOM 	   Partial loss of sight (scotoma) 	   Uncoordinated movements (ataxia) 	   Scintillation 	   Dizziness (vertigo) 	   Blurred vision 	   Ringing in ears (tinnitus) 	   Fortification spectra (zig-zag lines) 	   Decreased hearing acuity 	   Double vision 	   Decreased level of consciousness 	   Tingling or numbness (paresthesias) 	   Aphasia or unclassifiable speech 	   Weakness (paresis) 	   Poorly articulated speech (dysarthria) 	   Other:  	   Other:  	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APPENDIX 2 Cluster Headache Symptoms 
 
 
1. Have the headaches occurred in cluster periods?  	   	  Yes  	   	  No 
If YES, complete #1a 
If NO, skip to #2 
 
     1a. What is the total number of cluster periods experienced?   ____  
 
1b. What is the duration of cluster periods?   ____ d w m y (Indicate duration in days, weeks, months, or 
years) 
 
2. Are the headaches separated by remission periods?  	    Yes  	    No 
If YES, complete #2a 
If NO, skip to #3 
 
2a. What is the duration of remission periods?   ____ d w m y (Indicate duration in days, weeks, months, or 
years) 
 
3. Indicate which of the following symptoms are present, as well as side affected, during this type of headache: 
(Select all  
      that apply)  
 
 X SYMPTOM SIDE  X SYMPTOM SIDE 	   Red eyes (conjunctival injection) R     L 	   Forehead and facial sweating R     L 	   Tearing of the eyes (lacrimation) R     L 	   Pupillary constriction (miosis) R     L 	   Nasal congestion R     L 	   Drooping eyelids (ptosis) R     L 	   Runny nose (rhinorrhoea) R     L 	   Eyelid swelling (oedema) R     L 	   Restlessness or agitation  	   Other:   	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APPENDIX 3 Medication-Overuse Headache Symptoms 	   	  
 
1. Has the patient withdrawn from the overused medication?  	    Yes  	    No 
 If YES, complete #1a and #1b 
 If NO, skip to #2 
 
1a. Did headache resolve or revert to its previous pattern within 2 months after discontinuation of overused 
medication?  
 Yes  	    No 
 
1b. Has medication overuse ceased within the last 2 months, but headache has not resolved or reverted 
back to its previous pattern?  	    Yes  	  No 
 
2. Has intake of ergotamine, triptan, opioid OR combination of ergotamine, triptan, opioid, or analgesic occurred 
on 2 or more days per week, for 10 or more days per month, for greater than 3 months (Must not have 
combination overuse of any single class alone)?   	  Yes	  	  	   	  No 
If YES, indicate drug(s):   	    ergotamine  	    triptan  	    opioid   	  analgesic 
_____________________    
  
3. Has the patient’s intake of analgesic occurred on 2 or more days per week, for 15 or more days per month, 
for greater than 3 months?  	    Yes  	    No  
If YES, indicate drug: _____________________  
 
4. Has the patient’s intake of combination analgesics occurred on 2 or more days per week, for 10 or more 
days per month, for greater than 3 months?     Yes  	    No 
                If YES, indicate drugs: 
_______________________________________________________________ 
  
5. Has the patient’s intake of medication other than ergotamine, triptan, analgesic, or opioid occurred on a 
regular basis for greater than 3 months?  	   Yes  	    No 
                If YES, indicate drug: _____________________ 
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APPENDIX 4 Post-Traumatic Headache Symptoms 	  
 
1. Was there a loss of consciousness associated with head trauma?  	    Yes  	    No   
 If YES, complete #1a 
 If NO, skip to #2 
 
1a. What was the duration of unconsciousness?   ____ m h d (Indicate duration in minutes, hours, or days) 
 
2. Is head injury attributed to whiplash?  	    Yes  	   	  No 
 If YES, skip #5 through #8  
       If NO, complete #3 through #8 
 
3. Did headache develop within 7 days after head trauma (or after regaining consciousness)?  	    Yes  	    No 
 
4. How long has the headache continued? (Select most representative category) 
 	  Resolves within 3 months after head trauma 
 	  Persists for greater than 3 months after head trauma 
 	  Persists but 3 months have not passed since head trauma 
 
5. Did coma develop?  	    Yes  	    No  
 If YES, indicate severity on Glasgow Coma Scale:   	  GCS <13 [moderate/severe]   	  GCS >13 
[mild]       
 
6. Did post-traumatic amnesia develop and continue for longer than 48 hours?  	    Yes  	    No 
 
7. Did symptoms/signs develop diagnostic of a concussion?   	    Yes  	   	  No 
 
8. Were abnormal neuroimaging results attained suggestive of a traumatic brain lesion?  	    Yes  	  No 	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